|
|
| Research article summary (published 13 Oct 2009): |
Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
Full Abstract
Methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate (CDODA-Me) is a synthetic derivative of glycyrrhetinic acid, a triterpenoid phytochemical found in licorice extracts. CDODA-Me inhibited growth of RKO and SW480 colon cancer cells and this was accompanied by decreased expression of Sp1, Sp3 and Sp4 protein and mRNA and several Sp-dependent genes including survivin, vascular endothelial growth factor (VEGF), and VEGF receptor 1 (VEGFR1 or Flt-1). CDODA-Me also induced apoptosis, arrested RKO and SW480 cells at G(2)/M, and inhibited tumor growth in athymic nude mice bearing RKO cells as xenografts. CDODA-Me decreased expression of microRNA-27a (miR-27a), and this was accompanied by increased expression of 2 miR-27a-regulated mRNAs, namely ZBTB10 (an Sp repressor) and Myt-1 which catalyzes phosphorylation of cdc2 to inhibit progression of cells through G(2)/M. Both CDODA-Me and antisense miR-27a induced comparable responses in RKO and SW480 cells, suggesting that the potent anticarcinogenic activity of CDODA-Me is due to repression of oncogenic miR-27a.
Author information
Author/s: Chintharlapalli, Sudhakar (S); Papineni, Sabitha (S); Abdelrahim, Maen (M); Abudayyeh, Ala (A); Jutooru, Indira (I); Chadalapaka, Gayathri (G); Wu, Fei (F); Mertens-Talcott, Susanne (S); Vanderlaag, Kathy (K); Cho, Sung Dae (SD); Smith, Roger (R); Safe, Stephen (S);
Affiliation: Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77843-4466, USA.
Grants: R01CA108718 (Agency:NCI NIH HHS) ; R01CA112337 (Agency:NCI NIH HHS) ; R01CA135571 (Agency:NCI NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal: International journal of cancer. Journal international du cancer (Int J Cancer), published in United States. (Language: eng)
Reference: 2009-Oct; vol 125 (issue 8) : pp 1965-74
Dates: Created 2009/08/26; Completed 2009/09/21; Revised 2009/10/26;
PMID: 19582879, status: MEDLINE (last retrieval date: 10/27/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.
29 Apr 2007 - Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.
5 Nov 2007 - Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
30 Mar 2006 - [Effect of nitrogen-containing derivatives of the plant triterpenes betulin and glycyrrhetic acid on the growth of MT-4, MOLT-4, CEM, and Hep G2 tumor cells]
30 Oct 2007 - MicroRNA-143 and -145 in colon cancer.
29 Apr 2007 - Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro.
8 Jul 2007 - Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.
21 Jun 2008 - Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells.
5 Sep 2007 - The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.
30 Oct 2008 - Kaposi's sarcoma herpes virus taps into a host microRNA regulatory network.
15 Jan 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.